Inspira Technologies Oxy B.H.N. Ltd. 今日公布其融资方案定价细节,通过注册直接发行与同步私募配售共募集475万美元。此次发行严格遵循纳斯达克市场规则,采用市价定价机制,凸显了机构投资者对公司技术前景的认可。融资将专项用于推进其突破性血液氧合系统的临床研发与全球商业化布局,为重症监护领域带来颠覆性创新解决方案。
Inspira Technologies Oxy B.H.N. Ltd. 今日公布其融资方案定价细节,通过注册直接发行与同步私募配售共募集475万美元。此次发行严格遵循纳斯达克市场规则,采用市价定价机制,凸显了机构投资者对公司技术前景的认可。融资将专项用于推进其突破性血液氧合系统的临床研发与全球商业化布局,为重症监护领域带来颠覆性创新解决方案。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.